Results 21 to 30 of about 10,536,235 (262)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

RMD Open, 2021
Background We describe the early experiences of adults with systemic rheumatic disease who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an online, international survey of adults with systemic rheumatic disease who ...
S. Sattui, J. Liew, K. Kennedy, E. Sirotich, M. Putman, Tarin T Moni, A. Akpabio, D. Alpízar-Rodríguez, F. Berenbaum, I. Buliņa, R. Conway, A. Singh, Eimear Duff, K. Durrant, T. Gheita, C. Hill, Richard A Howard, B. Hoyer, E. Hsieh, Lina El Kibbi, Adam Kilian, A. H. Kim, D. Liew, Chieh Lo, B. Miller, S. Mingolla, M. Nudel, C. Palmerlee, J. Singh, Namrata Singh, M. Ugarte-Gil, J. Wallace, Kristen J Young, S. Bhana, W. Costello, R. Grainger, P. Machado, P. Robinson, P. Sufka, Z. Wallace, J. Yazdany, Carly Harrison, M. Larché, M. Levine, G. Foster, L. Thabane, L. Rider, J. Hausmann, J. Simard, J. Sparks   +49 more
semanticscholar   +1 more source

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

BMC Musculoskeletal Disorders, 2021
Background The purpose of this study was to determine the prevalence of high disease activity as measured using the Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients who nonetheless have low Bath Ankylosing ...
Bora Nam, Bon San Koo, Tae-Han Lee, Ji-Hui Shin, Jin-Ju Kim, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim   +7 more
doaj   +1 more source

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis

BMC Rheumatology, 2020
Background The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value.
Katie Bechman, Anthony Dalrymple, Charles Southey-Bassols, Andrew P. Cope, James B. Galloway   +4 more
doaj   +1 more source

Late Onset Dipeptidyl Peptidase -4 Inhibitor Associated Seronegative Rheumatoid Arthritis

Journal of Nepal Health Research Council, 2021
Drug-induced arthritis is not an uncommon scenario. DPP-4 inhibitors could potentially cause adverse-events mediated by cytokine-induced inflammation leading to arthritis. The activity of the DPP-4 enzyme could be inversely related to the development of
Binit Vaidya, Bhojraj Adhikari, Manisha Bhochhibhoya, Shweta Nakarmi   +3 more
doaj   +1 more source

Demyelination in rheumatic diseases [PDF]

Postgraduate Medical Journal, 2008
Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterised by multifocal areas of demyelination in the white matter of the brain and spinal cord. Autoantibodies, for example antinuclear antibodies, can also be present.
A, Theodoridou, L, Settas
openaire   +3 more sources

Evaluation of adherence to calcium, vitamin D and drugs for osteoporosis in patients with low bone mineral density [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2017
Introduction/Objective. Osteoporosis is a systemic disease of bone tissue, which leads to an increase in bone fragility and higher risk of fractures. The aim of the study was to determine adherence to calcium, vitamin D, and drugs for osteoporosis in ...
Maksimović Marina, Jurišić Vladimir, Erdeljan Biljana, Zvekić-Svorcan Jelena, Lazarević Biljana, Dojčinović Dragana   +5 more
doaj   +1 more source

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

Annals of the Rheumatic Diseases, 2022
Objective To develop recommendations for cardiovascular risk (CVR) management in gout, vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD), Sjögren’s syndrome (SS), systemic lupus erythematosus (SLE) and ...
G. Drosos, D. Vedder, E. Houben, L. Boekel, F. Atzeni, S. Badreh, D. Boumpas, N. Brodin, I. Bruce, M. González-Gay, S. Jacobsen, G. Kerekes, F. Marchiori, C. Mukhtyar, M. Ramos-Casals, N. Sattar, K. Schreiber, S. Sciascia, E. Svenungsson, Z. Szekanecz, A. Tausche, A. Tyndall, V. van Halm, A. Voskuyl, G. Macfarlane, M. Ward, M. Nurmohamed, Maria G. Tektonidou   +27 more
semanticscholar   +1 more source

Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis

Journal of Ayurveda and Integrative Medicine, 2018
Background: Data on long term use of Ayurvedic drugs is sparse. They may prove useful if combined with modern medicine in certain clinical situations (integrative medicine).
Arvind Chopra, Manjit Saluja, Toktam Kianifard, Deepa Chitre, Anuradha Venugopalan   +4 more
doaj   +1 more source

Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study

BMC Health Services Research, 2023
Background Remote care has the potential of improving access to timely care for people with inflammatory joint diseases (IJD), but there is limited knowledge on how this approach is regarded by healthcare professionals (HCP).
Emil Eirik Kvernberg Thomassen, Inger Jorid Berg, Eirik Klami Kristianslund, Anne Therese Tveter, Nina Østerås   +4 more
doaj   +1 more source

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study

RMD Open, 2023
Objective Gout is associated with lifestyle, body mass index (BMI) and comorbidities, including dyslipidaemia. We studied how in actively treated patients, anthropometric measures and lipid levels changed over 2 years and whether they predicted gout ...
Tore K Kvien, Joseph Sexton, Till Uhlig, Espen A Haavardsholm, Hilde Berner Hammer, Lars Fridtjof Karoliussen   +5 more
doaj   +1 more source